AKEBIA THERAPEUTICS, INC. Deferred Tax Assets, Property, Plant and Equipment
AKEBIA THERAPEUTICS, INC. (AKBA) had Deferred Tax Assets, Property, Plant and Equipment of $799.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2022-03-01
- 2021-12-31: Deferred Tax Assets, Property, Plant and Equipment $799.00K.
- 2020-12-31: Deferred Tax Assets, Property, Plant and Equipment $700.00K.
- 2019-12-31: Deferred Tax Assets, Property, Plant and Equipment $806.00K.
- 2014-12-31: Deferred Tax Assets, Property, Plant and Equipment $2.00K; Deferred Tax Assets, Property, Plant and Equipment as first filed $1.69K.
| Period end | Deferred Tax Assets, Property, Plant and Equipment | Deferred Tax Assets, Property, Plant and Equipment as first filed |
|---|---|---|
| 2021-12-31 | $799.00K 10-K · filed 2022-03-01 | |
| 2020-12-31 | $700.00K 10-K · filed 2022-03-01 | |
| 2019-12-31 | $806.00K 10-K · filed 2021-02-25 | |
| 2014-12-31 | $2.00K 10-K · filed 2016-03-14 | $1.69K 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |